Abstract
Although recent studies provide evidence for a common genetic basis between complex traits and Mendelian disorders, a thorough quantification of their overlap in a phenotype-specific manner remains elusive. Here, we quantify the overlap of genes identified through large-scale genome-wide association studies (GWAS) for 62 complex traits and diseases with genes known to cause 20 broad categories of Mendelian disorders. We identify a significant enrichment of phenotypically-matched Mendelian disorder genes in GWAS gene sets. Further, we observe elevated GWAS effect sizes near phenotypically-matched Mendelian disorder genes. Finally, we report examples of GWAS variants localized at the transcription start site or physically interacting with the promoters of phenotypically-matched Mendelian disorder genes. Our results are consistent with the hypothesis that genes that are disrupted in Mendelian disorders are dysregulated by noncoding variants in complex traits, and demonstrate how leveraging findings from related Mendelian disorders and functional genomic datasets can prioritize genes that are putatively dysregulated by local and distal non-coding GWAS variants.
Introduction
For decades, medical genetics has been bifurcated into two distinct fields: Mendelian genetics, which focuses on rare, high-impact mutations in single genes, and complex trait genetics, which utilizes Genome-Wide Association Studies (GWAS) to identify common variants with subtle effects. While these fields have traditionally operated in parallel, recent evidence suggests a shared biological architecture. This study systematically quantifies the overlap between these two architectures across 62 complex traits and 20 categories of Mendelian disorders. The central hypothesis is that genes underlying rare monogenic syndromes also serve as the biological "engines" for common traits, where common non-coding variants act as "volume knobs" that subtly dysregulate gene expression.
Methods
The researchers developed a robust pipeline to map the relationship between 3,446 Mendelian disorder genes and 62 complex traits.
- Gene Set Construction: 20 broad categories of Mendelian disorders (e.g., "Growth Defects," "Immune Dysregulation") were curated from the Online Mendelian Inheritance in Man (OMIM) database and mapped to relevant GWAS traits.
- GWAS Mapping: GWAS gene sets were defined by identifying the closest upstream and downstream protein-coding genes for every significant single-nucleotide polymorphism (SNP) across the 62 traits.
- Enrichment Analysis: Fisher’s Exact Tests were employed to determine if GWAS genes for a specific trait were significantly enriched with Mendelian genes from a phenotypically related category.
- Signal Quantification: The researchers calculated the average effect size (Z-score) of GWAS variants near different gene classes to assess if the genetic signal was stronger in the proximity of Mendelian genes.
- Functional Validation: To move beyond simple proximity, the team used fine-mapping (fgwas) and 3D chromosomal interaction data (Hi-C) from primary human white adipocytes to identify physical interactions between common variants and the promoters of Mendelian genes.
Key Results
Phenotype-Specific Enrichment
The study identified 51 pairs of complex traits and Mendelian disorders with significant, phenotypically matched enrichment. For instance, genes associated with height in GWAS were significantly enriched near genes causing skeletal disorders, while cholesterol-related GWAS hits were concentrated near genes involved in lipid metabolism disorders. This specificity suggests that the overlap is driven by shared biological pathways rather than a general property of all disease-related genes.
Elevated Effect Sizes
GWAS variants located near phenotypically matched Mendelian genes exhibited significantly higher average effect sizes compared to variants near random protein-coding genes. This suggests that these regions are not only statistically enriched but also harbor variants with greater impact on the trait's variance.
Regulatory Mechanisms and 3D Interactions
The study identified 25 candidate SNPs located precisely at the transcription start sites (TSS) of Mendelian genes. A notable example includes a coronary artery disease-associated variant mapped directly to the promoter of LIPA, a gene responsible for rare cholesterol storage disorders. Furthermore, Hi-C data revealed that BMI-associated variants often physically loop across the genome to interact with the promoters of genes like CREBBP, which is linked to Rubinstein-Taybi Syndrome (a condition characterized by obesity).
Discussion
These findings support a "spectrum" model of genetic architecture, where a single gene can be a functional unit for both rare and common diseases. A severe coding mutation may result in a Mendelian disorder, while a non-coding regulatory variant contributes to a complex trait.
Additionally, the study found that genes highly sensitive to any mutation (LOF-intolerant), as identified by the Exome Aggregation Consortium (ExAC), also showed higher GWAS signals. This suggests that many "essential" genes, where severe mutations might be embryonic lethal, still contribute to common trait variation through subtle dysregulation.
Limitations and Future Directions
While mapping GWAS hits to the nearest gene is a standard proxy, the authors acknowledge its limitations, as regulatory variants can target distal genes. Future work will benefit from increased GWAS power, particularly for traits like Autism that currently show lower enrichment. Ultimately, this phenotype-driven approach provides a framework for prioritizing drug targets by focusing on genes already known to have a profound impact on human health through their roles in Mendelian disorders.
Summary updated